v3.26.1
Business Combinations (Tables)
 12 Months Ended
Dec. 31, 2025
Business Combination [Line Items]  
Schedule of Assets and Liabilities Held for Disposal

The carrying amounts of major classes of assets and liabilities held for disposal are as follows:

  

   December 31, 2024 
ASSETS     
Cash  $121,876 
Prepaid expenses and other current assets   1,437 
Intangible assets, net   14,828,000 
Goodwill   17,656,707 
Total assets held for sale  $32,608,020 
LIABILITIES     
Accounts payable and accrued liabilities  $4,009,743 
Notes payable, net   284,778 
Total liabilities held for sale  $4,294,521 

 

The major classes of line items constituting loss from discontinued operations are as follows:

 

       
   For the Year Ended 
   December 31, 
   2025   2024 
Revenue  $-   $- 
Cost of revenue   -    - 
Selling, general and administrative expenses   1,408,305    1,013,003 
Research and development expenses   393,470    484,780 
Impairment loss   14,645,069    - 
Depreciation and amortization   -    - 
Interest expense   5,718    21,217 
Loss on discontinued operations  $16,452,562   $1,519,000 
Five Narrow Lane LP [Member]  
Business Combination [Line Items]  
Schedule of Allocation of Purchase Price

The allocation of the purchase price is as follows:

  

      
Consideration given:    
Common Stock  $214,937 
NAYA Acquisition Pre-funded Warrants   300,978 
Series C-1 Preferred   17,691,000 
Series C-2 Preferred   7,457,000 
Convertible Debenture   3,934,146 
Business acquisition cost   29,598,061 
Assets and liabilities acquired:     
Cash   472,008 
Other current assets   40,747 
Tradename   257,000 
In process R&D   14,571,000 
Goodwill   17,656,707 
AP & accrued liabilities   (3,109,039)
Debt   (290,362)
Total assets and liabilities acquired  $29,598,061 
NAYA Therapeutics [Member]  
Business Combination [Line Items]  
Schedule of Allocation of Purchase Price

The Company recognized a loss of $1,534,517 upon the disposition of the 80.1% ownership of NTI.

  

      
Consideration received:    
Series C-1 Preferred   2,466,810 
NTI Note Receivable   4,803,175 
NTI Series A Preferred   3,879,611 
Business acquisition cost  $11,149,596 
      
Assets and liabilities divested:     
Cash   6,569 
Other current assets   16,700 
Tradename   257,000 
In process R&D   14,571,000 
Goodwill   3,011,638 
AP & accrued liabilities   (4,804,016)
Debt   (374,778)
Net assets  $12,684,113 
      
Loss on disposition  $1,534,517